One hundred fifty-two cognitively unimpaired older adults (63 ± 5 years, 102 female, 59 APOE4), from the Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease (PREVENT-AD) cohort45,46 were included. This evidence concerns the gene APOE and Alzheimer disease.